Regenacy
is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of diabetics... Read moreRegenacy
is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of diabetics... Read more
News
Aug 25, 2022
VC News Daily
Regenacy: Regenacy Pharmaceuticals Inks $9.3M Series B
Dec 21, 2020
Business Wire
Press Release: Regenacy : Regenacy Announces the Formation of a Joint Venture with 3E Bioventures to Develop Ricolinostat in China and the Start of a U.S. Phase 2 Study in Painful Diabetic Peripheral Neuropathy
Mar 27, 2020
DealStreetAsia
Regenacy Pharmaceuticals: China Digest: UK's Ability buys Bristol hotel from CIMC Capital; Cobro Ventures and Taiwania Capital co-lead $30m in Regenacy
Mar 25, 2020
FinSMEs
Regenacy Pharmaceuticals: Regenacy Pharmaceuticals Secures $30M in Series A Financing
Mar 25, 2020
BioPortfolio
Regenacy Pharmaceuticals: Regenacy Pharma Raises $30M for Nerve Function Restoring Treatments
Mar 25, 2020
firstword pharma
Regenacy Pharmaceuticals: Regenacy Pharmaceuticals Raises $30 Million in Series A Financing
Mar 25, 2020
Talent4Boards
Regenacy Pharmaceuticals: Regenacy Pharma strengthens its Board along with raising $30m Series A financing co-led by Cobro Ventures and Taiwania Capital
Aug 16, 2018
BioPortfolio
Regenacy Pharmaceuticals: Regenacy Pharmaceuticals Announces Patent Issuance for Ricolinostat to Treat Diabetic Peripheral Neuropathy
Apr 17, 2018
Business Wire
Press Release: Regenacy Pharmaceuticals : Regenacy Pharmaceuticals Appoints Dr. William W. Chin to Board of Directors and Scientific Advisory Board
Apr 17, 2018
BioPortfolio
Regenacy Pharmaceuticals: Regenacy Pharmaceuticals Appoints Dr. William W. Chin to Board of Directors and Scientific Advisory Board
Regenacy Competitors
1
2
3
4
5
6
7
8
9
10